These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12392704)

  • 1. Secretory leukocyte protease inhibitor: inhibition of human immunodeficiency virus-1 infection of monocytic THP-1 cells by a newly cloned protein.
    Shine NR; Wang SC; Konopka K; Burks EA; Düzgüneş N; Whitman CP
    Bioorg Chem; 2002 Aug; 30(4):249-63. PubMed ID: 12392704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription.
    McNeely TB; Shugars DC; Rosendahl M; Tucker C; Eisenberg SP; Wahl SM
    Blood; 1997 Aug; 90(3):1141-9. PubMed ID: 9242546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro.
    McNeely TB; Dealy M; Dripps DJ; Orenstein JM; Eisenberg SP; Wahl SM
    J Clin Invest; 1995 Jul; 96(1):456-64. PubMed ID: 7615818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus type-1 (HIV-1) replication is unaffected by human secretory leukocyte protease inhibitor.
    Turpin JA; Schaeffer CA; Bu M; Graham L; Buckheit RW; Clanton D; Rice WG
    Antiviral Res; 1996 Mar; 29(2-3):269-77. PubMed ID: 8739605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory function of secretory leukocyte proteinase inhibitor (SLPI) in human saliva is HIV-1 specific and varies with virus tropism.
    Skott P; Lucht E; Ehnlund M; Björling E
    Oral Dis; 2002 May; 8(3):160-7. PubMed ID: 12108760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secretory leukocyte protease inhibitor (SLPI): oxidation of SLPI does not explain its variable anti-HIV activity.
    Konopka K; Shine N; Pretzer E; Düzgüneş N
    J Dent Res; 1999 Dec; 78(12):1773-6. PubMed ID: 10598905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV-I.
    Wahl SM; McNeely TB; Janoff EN; Shugars D; Worley P; Tucker C; Orenstein JM
    Oral Dis; 1997 May; 3 Suppl 1():S64-9. PubMed ID: 9456660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretory leukocyte protease inhibitor blocks infectivity of primary monocytes and mononuclear cells with both monocytotropic and lymphocytotropic strains of human immunodeficiency virus type I.
    Shugars DC; Sauls DL; Weinberg JB
    Oral Dis; 1997 May; 3 Suppl 1():S70-2. PubMed ID: 9456661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human immunodeficiency virus type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: a role for SLPI in innate mucosal immunity.
    Jana NK; Gray LR; Shugars DC
    J Virol; 2005 May; 79(10):6432-40. PubMed ID: 15858026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretory leukocyte protease inhibitor inhibits infection of monocytes and lymphocytes with human immunodeficiency virus type 1 but does not interfere with transcytosis of cell-associated virus across tight epithelial barriers.
    Hocini H; Becquart P; Bouhlal H; Adle-Biassette H; Kazatchkine MD; Bélec L
    Clin Diagn Lab Immunol; 2000 May; 7(3):515-8. PubMed ID: 10799472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive and regulated secretion of secretory leukocyte proteinase inhibitor by human intestinal epithelial cells.
    Si-Tahar M; Merlin D; Sitaraman S; Madara JL
    Gastroenterology; 2000 Jun; 118(6):1061-71. PubMed ID: 10833481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anatomic dissociation between HIV-1 and its endogenous inhibitor in mucosal tissues.
    Wahl SM; Worley P; Jin W; McNeely TB; Eisenberg S; Fasching C; Orenstein JM; Janoff EN
    Am J Pathol; 1997 Apr; 150(4):1275-84. PubMed ID: 9094984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous salivary inhibitors of human immunodeficiency virus.
    Shugars DC; Alexander AL; Fu K; Freel SA
    Arch Oral Biol; 1999 Jun; 44(6):445-53. PubMed ID: 10401522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary secretory leukocyte protease inhibitor is associated with reduced transmission of human immunodeficiency virus type 1 through breast milk.
    Farquhar C; VanCott TC; Mbori-Ngacha DA; Horani L; Bosire RK; Kreiss JK; Richardson BA; John-Stewart GC
    J Infect Dis; 2002 Oct; 186(8):1173-6. PubMed ID: 12355371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced secretory leukocyte protease inhibitor in human immunodeficiency virus type 1-infected patients.
    Baqui AA; Meiller TF; Falkler WA
    Clin Diagn Lab Immunol; 1999 Nov; 6(6):808-11. PubMed ID: 10548568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential inhibition of mast cell chymases by secretory leukocyte protease inhibitor.
    Pemberton AD; Huntley JF; Miller HR
    Biochim Biophys Acta; 1998 Jan; 1379(1):29-34. PubMed ID: 9468329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel secretory leukocyte protease inhibitor-binding protein involved in membrane phospholipid movement.
    Tseng CC; Tseng CP
    FEBS Lett; 2000 Jun; 475(3):232-6. PubMed ID: 10869562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cysteine proteases of Trichomonas vaginalis degrade secretory leukocyte protease inhibitor.
    Draper D; Donohoe W; Mortimer L; Heine RP
    J Infect Dis; 1998 Sep; 178(3):815-9. PubMed ID: 9728551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretory leukocyte protease inhibitor binds to annexin II, a cofactor for macrophage HIV-1 infection.
    Ma G; Greenwell-Wild T; Lei K; Jin W; Swisher J; Hardegen N; Wild CT; Wahl SM
    J Exp Med; 2004 Nov; 200(10):1337-46. PubMed ID: 15545357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretory leukocyte protease inhibitor is a novel inhibitor of fibroblast-mediated collagen gel contraction.
    Sumi Y; Muramatsu H; Hata K; Ueda M; Muramatsu T
    Exp Cell Res; 2000 Apr; 256(1):203-12. PubMed ID: 10739667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.